SENTI BIOSCIENCES
Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost.
SENTI BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sentibio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
215.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Font Awesome Apache Nginx Amazon IPv6
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
8VC
8VC investment in Post-IPO Equity - Senti Biosciences
Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Post-IPO Equity - Senti Biosciences
Morgan Stanley Investment Management
Morgan Stanley Investment Management investment in Post-IPO Equity - Senti Biosciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Senti Biosciences
Invus
Invus investment in Post-IPO Equity - Senti Biosciences
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Senti Biosciences
Amgen Ventures
Amgen Ventures investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Convertible Note - Senti Biosciences
National Cancer Institute
National Cancer Institute investment in Grant - Senti Biosciences
Key Employee Changes
Official Site Inspections
http://www.sentibio.com Semrush global rank: 4 M Semrush visits lastest month: 3.11 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Senti Biosciences"
About - Senti Bio
Contact. 2 Corporate Drive, First Floor South San Francisco, CA 94080. Follow Legal. Terms of UseSee details»
SEC Filing - Senti Biosciences, Inc.
Organization and Description of Business. Senti Biosciences, Inc. and its subsidiaries (the “Company” or “Senti”), is a biotechnology company that was founded to create a new …See details»
Overview - Senti Bio
New Medicines Require a New Way of Thinking Our Mission Senti Bio was founded to create a new generation of smarter medicines that outsmart complex diseases using novel and …See details»
Senti Bio Company Profile | Management and Employees List
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . Python Python . CSS World Wide Web Consortium . PHP PHP . …See details»
Senti Biosciences - Crunchbase Company Profile
Contact Email [email protected] Senti Biosciences is a biotechnology company focused on synthetic biology and gene circuit engineering for therapeutic applications. Senti Bio utilizes a synthetic biology platform named …See details»
SENTI BIOSCIENCES, INC.
Government, non-profit or academic organization of high standing. The nominee shall be highly accomplished in his or her respective field, with superior credentials and recognition. The …See details»
Senti Biosciences - Company Profile - Tracxn
Dec 13, 2024 Senti Biosciences - Developer of cell-based therapies for cancer treatment. Raised a total funding of $196M over 3 rounds from 30 investors. Founded by Tim Lu, Philip …See details»
Senti Bio - Overview, News & Similar companies | ZoomInfo.com
May 9, 2024 Senti Bio contact info: Phone number: (650) 382-3281 Website: www.sentibio.com What does Senti Bio do? Founded in 2016 and headquartered in South San Francisco, …See details»
Team - Senti Bio
Ms. Li has been serving as our interim Chief Financial Officer and Treasurer since May 2024. She is a seasoned finance executive with more than 25 years of extensive experience in equity financing, strategic financial planning and …See details»
SEC Filing | Senti Biosciences, Inc. - investors.sentibio.com
Dec 2, 2024 Item 1. Security and Issuer. This Amendment No. 1 to Schedule 13D amends and supplements the Schedule 13D originally filed on July 15, 2022 (the “Schedule 13D”), and …See details»
Senti Bio Appoints Fran Schulz to Board of Directors - Yahoo Finance
Dec 2, 2024 Biotechnology industry executive with a proven track record of advising management teams on corporate and financial strategy for more than 30 yearsSOUTH SAN …See details»
Senti Biosciences Announces New Employment Inducement Grants
Dec 4, 2024 SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company …See details»
Senti Bio Announces Third Quarter 2024 Results and Recent …
Nov 14, 2024 Investors and others should note that we communicate with our investors and the public using our company website (www.sentibio.com), including, but not limited to, company …See details»
Scientific Advisory Board - Senti Bio
Most recently he was the Chief Commercial Officer at Seagen, leading the organization for the launches of PADCEV (enfortumab vedotin) and Tukysa (tucatinib). He began his career at …See details»
Board of Directors - Senti Bio
Dr. Cooperstone has served as a member of our board of directors since 2019. Dr. Cooperstone has held various leadership positions at Pfizer including as Senior Vice President since 2017, …See details»
Senti Biosciences | Careers
Join Senti Bio and help build the next generation therapeutics. We are driven to create medicines that are programmable, controllable and designed to tackle even the most challenging …See details»
Senti Bio Announces Second Quarter 2024 Results and Reviews …
Aug 13, 2024 Investors and others should note that we communicate with our investors and the public using our company website (www.sentibio.com), including, but not limited to, company …See details»
Overview - Senti Bio
Senti Bio is a clinical-stage company that has built a synthetic biology platform that enables us to program next-generation cell and gene therapies with Gene Circuits.See details»
Release Details - investors.sentibio.com
Dec 2, 2024 SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage …See details»